Aldevron

In gene-modified cell therapy, manufacturing success starts long before cGMP production. Decisions made during plasmid design can influence reproducibility, scalability, and overall program efficiency throughout development. Yet many organizations still approach vector design, critical materials, and manufacturing as separate activities. Join us on September 8 as industry experts discuss practical strategies for building a more connected workflow from early development through commercialization. Key discussion topics:   ✅ How plasmid design impacts downstream performance ✅ Approaches to improve consistency and reduce variability ✅ Considerations for scaling manufacturing processes ✅ Common points of disconnect and how to address them September 8, 2026 | 10:30 AM EDT / 4:30 PM CEST Register today: https://ald.bio/3TDvDUN #CellTherapy #GeneModifiedCellTherapy #CGT #PlasmidDNA #Biomanufacturing #GMP #GeneEditing

How do you accelerate RNA capping process development without sacrificing analytical confidence? As mRNA-based vaccines and therapeutics advance, development teams need analytical workflows that can evaluate more samples, compare process conditions efficiently, and support faster decision-making. In this presentation, Rebecca Young explores how combining InDevR's VaxArray® 5'CapQ assay with HPLC-based methods can help streamline RNA capping process development. The approach pairs high-throughput analysis with detailed confirmation, providing valuable insight into capping efficiency and RNA integrity from early R&D through manufacturing readiness. Read the presentation highlights: https://ald.bio/4wrcEub #mRNA #RNATherapeutics #ProcessDevelopment #Bioprocessing #Biomanufacturing #AnalyticalDevelopment

RNA is no longer a niche technology. It underpins vaccines, enables gene editing workflows, and continues to unlock new therapeutic possibilities across biotechnology. In recognition of RNA Day this past weekend, we're putting a fundamental mRNA manufacturing question to the test: #RNADay #RNA #mRNA #BiotechTrivia #Aldevron

The field of RNA therapeutics continues to expand beyond its traditional role as a messenger molecule. Today, advances in mRNA, RNA editing, circular RNA, and antisense technologies are creating new opportunities to address complex diseases. On July 29, GEN's Spotlight on RNA Therapeutics will bring together leading researchers to discuss emerging trends shaping the future of RNA-based medicines. As a sponsor of this event, Aldevron looks forward to contributing to the conversation and celebrating RNA Day with the scientific community. Learn more and register: https://ald.bio/44UmJ7y #RNATherapeutics #RNADay #LifeSciences #Biopharma #PrecisionMedicine

Momentum can accelerate innovation. Discipline helps sustain it. As AAV-based therapies continue to advance, organizations face important decisions around development strategy, manufacturing readiness, and long-term scalability. Our latest blog post examines the balance between speed and discipline required to keep programs moving forward. Read the blog post: https://ald.bio/4wGwlia #AAV #GeneTherapy #CGT #Bioprocessing #Biomanufacturing #Biotech

I'll be attending SITGEC in Milan on July 17–18 and look forward to connecting with colleagues and industry professionals!   Meetings like this are always a good chance to step back and look at where C&G is headed, especially as programs transition from early research into development and scale. Interested to hear how others are approaching some of the common challenges across the field.   If you’re attending, feel free to reach out and connect during the event: https://lnkd.in/ee4J_dte #SITGEC2026 #CellTherapy #GeneTherapy #Biotech #CDMO #Aldevron #AdvancedTherapies #LifeSciences

As mRNA-based therapies continue to advance across vaccines, oncology, and personalized medicine, manufacturers face a critical challenge: delivering high performance while reducing environmental impact. In Aldevron's latest blog, we explore how innovation in in vitro transcription (IVT) enzyme selection can help support both manufacturing efficiency and sustainability goals. As regulatory expectations and environmental considerations evolve, sustainable approaches are becoming an increasingly important part of mRNA process development and production. Read the blog to learn how the industry is balancing technical excellence with environmental responsibility in mRNA manufacturing. 📖 Read more: https://ald.bio/4f4wvsl #mRNA #Biopharma #SustainableManufacturing #RNA #CellAndGeneTherapy #Biotechnology #Bioprocessing #LifeSciences #Innovation #Aldevron

Happy Independence Day from Aldevron. Wishing you a great day filled with good food, fireworks, and time spent with the people who matter most. Stay safe and enjoy the celebration. #IndependenceDay #FourthOfJuly #StaySafe

Aldevron offices will be closed on July 3 in observance of Independence Day. Our teams will resume normal operations on July 6. If you need support in the meantime, please reach out to your Aldevron contact and we will follow up as soon as possible upon return. We appreciate your partnership and wish you a meaningful holiday. #FourthOfJuly #IndependenceDay #HolidayNotice #LifeSciences

Relive the insights, innovations, and discussions that are shaping the future of genomic medicine discussed at last year's Advanced Beyond Symposium. Whether you attended or missed the event, this is your chance to catch up on the fantastic insights, inspiring stories, and incredible science. Watch the symposium here: https://lnkd.in/edTx3vvv Don't miss out! What was your favorite takeaway from the symposium? #GenomicMedicine #Innovation #Aldevron #BiotechEvents #AdvancedBeyond